Market Access The Windsor Framework: Insights on the regulatory shift for ... The Windsor Framework marks a significant change in the UK's post-Brexit regulatory space, particularly for the pharmaceutical sector
Market Access Approaching the regulatory world with passion: CERs and EU M... There has been significant evolution in the European regulatory landscape over the past 10 years, particularly in terms of requirements for clinical evaluation, driven in part by
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.